Identification of targets for rational pharmacological therapy in childhood craniopharyngioma.
about
Craniopharyngioma and hypothalamic injury: latest insights into consequent eating disorders and obesity.Adamantinomatous and papillary craniopharyngiomas are characterized by distinct epigenomic as well as mutational and transcriptomic profilesEpCAM (CD326) is differentially expressed in craniopharyngioma subtypes and Rathke's cleft cystsDownregulation of miR-137 and miR-6500-3p promotes cell proliferation in pediatric high-grade gliomas.Combined EphB2 receptor knockdown with radiation decreases cell viability and invasion in medulloblastoma.Genetically engineered mouse models of craniopharyngioma: an opportunity for therapy development and understanding of tumor biology.Risk-adapted treatment and follow-up management in childhood-onset craniopharyngioma.Risk-adapted, long-term management in childhood-onset craniopharyngioma.New outlook on the diagnosis, treatment and follow-up of childhood-onset craniopharyngioma.Recent advances in molecular pathology of craniopharyngioma.Distinct patterns of primary and motile cilia in Rathke's cleft cysts and craniopharyngioma subtypes.The Stem Cell Connection of Pituitary Tumors.Models of human adamantinomatous craniopharyngioma tissue: Steps toward an effective adjuvant treatment.Pediatric Craniopharyngiomas: A Primer for the Skull Base Surgeon.Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK/ERK pathway as a novel therapeutic target.Characterization of the murine orthotopic adamantinomatous craniopharyngioma PDX model by MRI in correlation with histology.
P2860
Q36429199-7E3E18E4-1A6E-4F8F-A3F9-005EFADA488BQ36629324-C0C9545C-B295-4FA2-87BE-652C26071DFFQ37105120-FEB7F2BB-F680-4BCD-BF71-8439CA37F9DBQ37190159-2C840161-483D-4661-B533-59239A6AB934Q37727021-D9F84922-CF51-4318-AD87-977FA7542779Q38729611-68B63800-E2DC-42CA-88CF-36E2890E1D18Q38776792-F87DA569-1396-47D3-8AB3-47F3D55F21D3Q38948869-AC436A08-0DDE-4020-8F27-564D895A8F6FQ39117386-18F193AE-EDBF-4E15-854D-28A6CE973E19Q41150936-D868E359-D3F7-4709-A5CD-74032ED709DBQ42248290-17A4C82C-B910-4551-BECF-9CC1ADD9369DQ47122908-87B8EA09-7A4C-4D49-94F6-2B69404EA628Q48269479-B8F78C45-570E-4D2E-96D7-491E2EC3CA6DQ50060950-18D6214D-7D71-41D1-862F-B216DDF34222Q52354928-3F1FE4FC-E8B1-4BC0-BC9C-76FAB56727E1Q55383644-A3A31D9D-3023-4011-BDF5-188EB38B1304
P2860
Identification of targets for rational pharmacological therapy in childhood craniopharyngioma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Identification of targets for ...... n childhood craniopharyngioma.
@ast
Identification of targets for ...... n childhood craniopharyngioma.
@en
type
label
Identification of targets for ...... n childhood craniopharyngioma.
@ast
Identification of targets for ...... n childhood craniopharyngioma.
@en
prefLabel
Identification of targets for ...... n childhood craniopharyngioma.
@ast
Identification of targets for ...... n childhood craniopharyngioma.
@en
P2093
P2860
P1476
Identification of targets for ...... n childhood craniopharyngioma.
@en
P2093
Amy Rosenfeld
Andrea M Griesinger
Andrew M Donson
B K Kleinschmidt-DeMasters
Diane K Birks
Jacob M Gump
James M Johnston
Karun K Rao
Michael Handler
P2860
P2888
P356
10.1186/S40478-015-0211-5
P577
2015-05-21T00:00:00Z
P5875
P6179
1036733063